<DOC>
	<DOC>NCT01359254</DOC>
	<brief_summary>The primary objective of this study is to assess the rate of engraftment with combined haploidentical-cord blood transplantation in patients with pre-existing donor specific antibodies and in those with active disease.</brief_summary>
	<brief_title>Cord Blood Transplantation for Patients With Cancer</brief_title>
	<detailed_description>Primary Objective - To assess the rate of engraftment with combined haploidentical-cord blood transplantation in patients with pre-existing donor specific anti-HLA antibodies and in those with active disease Secondary Objectives - To determine the long term fate of the haplo transplant and the cord blood transplant in this setting. - To describe the incidence and severity of acute and chronic GVHD.</detailed_description>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Relapsed or refractory acute leukemia (myeloid or lymphoid) Acute leukemia in first remission at highrisk for recurrence Chronic myelogenous leukemia in accelerated phase or blastcrisis Chronic myelogenous leukemia in chronic phase Recurrent or refractory malignant lymphoma or Hodgkin lymphoma Chronic lymphocytic leukemia, relapsed or with poor prognostic features Multiple myeloma Myelodysplastic syndrome Chronic myeloproliferative disease Hemoglobinopathies Aplastic anemia Zubrod performance status &gt; 2 Life expectancy is severely limited by concomitant illness Patients with severely decreased LVEF or impaired pulmonary function tests Estimated Creatinine Clearance &lt;50 ml/min Serum bilirubin&gt; 2.0 mg/dl or SGPT &gt;3 x upper limit of normal Evidence of chronic active hepatitis or cirrhosis HIVpositive Patient is pregnant Patient or guardian not able to sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>